Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
Shranjeno v:
| izdano v: | BMC Research Notes vol. 11 (2018), p. 1 |
|---|---|
| Glavni avtor: | |
| Drugi avtorji: | , , , , , , , , , |
| Izdano: |
Springer Nature B.V.
|
| Teme: | |
| Online dostop: | Citation/Abstract Full Text Full Text - PDF |
| Oznake: |
Brez oznak, prvi označite!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 2791325874 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 1756-0500 | ||
| 024 | 7 | |a 10.1186/s13104-018-3623-z |2 doi | |
| 035 | |a 2791325874 | ||
| 045 | 2 | |b d20180101 |b d20181231 | |
| 084 | |a 113109 |2 nlm | ||
| 100 | 1 | |a Atif Ali Hashmi | |
| 245 | 1 | |a Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast | |
| 260 | |b Springer Nature B.V. |c 2018 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a Objectives The aim of this study was to determine the frequency of metaplastic breast carcinoma and invasive micropapillary carcinoma in our population and also to compare the clinico-pathologic features of metaplastic breast carcinoma and invasive micropapillary carcinoma with invasive ductal carcinoma, not otherwise specified (IDC, NOS). Results 86.9% of the cases were identified as ductal carcinoma, NOS, while 2.2% were metaplastic and 0.76% cases were micropapillary carcinoma. Metaplastic carcinomas were found to be of higher grade as compared to IDC, NOS as 81% of metaplastic carcinoma were grade III compared to 35% IDC, NOS. 79% of metaplastic carcinoma were ER negative and 86% were PR negative, respectively as compared to ductal carcinoma NOS, which were 40% ER negative and 54% were PR. Similarly, 86.7% micropapillary cancers were ER positive and 73.3% were PR positive. Moreover, 66.7% micropapillary carcinoma showed nodal metastasis and 77.8% showed lymphovascular invasion, which was significantly higher than that of IDC, NOS micropapillary and metaplastic carcinomas accounts for less than 2 and 1% of the breast cancer burden in our population and highly correlates with poor prognosis parameters therefore, require more intensive management in our population. | |
| 653 | |a Laboratories | ||
| 653 | |a Breast carcinoma | ||
| 653 | |a Metastasis | ||
| 653 | |a Metastases | ||
| 653 | |a Gene amplification | ||
| 653 | |a Tumors | ||
| 653 | |a Lymphatic system | ||
| 653 | |a Cloning | ||
| 653 | |a Breast cancer | ||
| 653 | |a Invasiveness | ||
| 700 | 1 | |a Aijaz, Saher | |
| 700 | 1 | |a Mahboob, Raeesa | |
| 700 | 1 | |a Saadia Mehmood Khan | |
| 700 | 1 | |a Muhammad Irfan | |
| 700 | 1 | |a Narisa Iftikhar | |
| 700 | 1 | |a Nisar, Mariam | |
| 700 | 1 | |a Siddiqui, Maham | |
| 700 | 1 | |a Edhi, Muhammad Muzzammil | |
| 700 | 1 | |a Faridi, Naveen | |
| 700 | 1 | |a Khan, Amir | |
| 773 | 0 | |t BMC Research Notes |g vol. 11 (2018), p. 1 | |
| 786 | 0 | |d ProQuest |t Health & Medical Collection | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/2791325874/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/2791325874/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/2791325874/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |